A Clinical trial to study the effects of Homoeopathic Medicines in patients with Parkinsons Disease.

An Exploratory Clinical Study to find out the Effectiveness of Homoeopathic Medicines in the management of Parkinsons Disease - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059894

Enrollment

Registered

2023-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Homoeopathic medicines: The administration of homeopathic medicines will be based on a comprehensive assessment of the patients case, utilizing repertorization with the relevant reperto

Eligibility

Inclusion criteria

Inclusion criteria: Modified Hoehn and Yahr scale upto stage 4

Exclusion criteria

Exclusion criteria: 1. Individuals diagnosed with other significant Neurological disorders such as multiplesclerosis, Motor neuron disorders, and Malignancies. 2.Uncontrolled Diabetes Mellitus and Hypertension, and any severe life-threatening medical illness.

Design outcomes

Primary

Measure	Time frame
Cases will be assessed using the MDS-sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) for the Parkinson’s disease.Timepoint: 10 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr SGSChakravarthy

National Homoeopathy Research Institute in Mental Health, Kottayam, Kerala

sgschakravarthy@gmail.com9908019739

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026